GUANFACINE HYDROCHLORIDE

GUANFACINE HYDROCHLORIDE was reported 4719 times

GUANFACINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLYCOGEN STORAGE DISEASE TYPE VIII 3 0.2143
1 MACULAR DETACHMENT 18 0.0744
2 DISRUPTIVE MOOD DYSREGULATION DISORDER 5 0.0676
3 SELECTIVE MUTISM 5 0.0595
4 ANTICHOLINERGIC EFFECT 4 0.0533
5 SWEAT TEST ABNORMAL 3 0.0441
6 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 4 0.0426
7 FORCED EXPIRATORY VOLUME ABNORMAL 6 0.0414
8 OPPOSITIONAL DEFIANT DISORDER 16 0.0405
9 DEFIANT BEHAVIOUR 12 0.0390
10 RESTLESS LEG AUGMENTATION SYNDROME 5 0.0323
11 CHOROIDAL EFFUSION 22 0.0274
12 INTERMITTENT EXPLOSIVE DISORDER 3 0.0256
13 CATHETER SITE DISCOLOURATION 3 0.0246
14 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 4 0.0223
15 HYPERTENSIVE URGENCY 11 0.0199
16 WITHDRAWAL HYPERTENSION 4 0.0198
17 SELF-DESTRUCTIVE BEHAVIOUR 17 0.0195
18 VENTRICULAR DYSKINESIA 4 0.0192
19 GRANDIOSITY 7 0.0191
20 ATRIOVENTRICULAR DISSOCIATION 4 0.0187
21 BODY MASS INDEX DECREASED 8 0.0173
22 BLOOD PROLACTIN DECREASED 3 0.0171
23 DRUG-GENETIC INTERACTION 6 0.0168
24 NEPHROGENIC DIABETES INSIPIDUS 19 0.0165
25 OROMANDIBULAR DYSTONIA 12 0.0165
26 CHORIORETINAL DISORDER 3 0.0152
27 BRIEF RESOLVED UNEXPLAINED EVENT 2 0.0152
28 ACTIVATION SYNDROME 5 0.0145
29 DISTRACTIBILITY 14 0.0121
30 SEROUS RETINAL DETACHMENT 10 0.0119
31 DERMATILLOMANIA 7 0.0117
32 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 5 0.0112
33 ANION GAP 7 0.0110
34 PERIODIC LIMB MOVEMENT DISORDER 4 0.0109
35 ACANTHOSIS NIGRICANS 2 0.0108
36 CHOROIDAL DETACHMENT 6 0.0108
37 IMPULSIVE BEHAVIOUR 40 0.0106
38 BRUGADA SYNDROME 11 0.0106
39 TRICHOTILLOMANIA 6 0.0102
40 ADULTERATED PRODUCT 2 0.0100
41 BRADYPNOEA 27 0.0100
42 ELECTROCARDIOGRAM T WAVE PEAKED 4 0.0100
43 ELECTROCARDIOGRAM QT SHORTENED 3 0.0099
44 SINUS ARREST 15 0.0096
45 TIC 51 0.0093
46 CATHETER SITE BRUISE 3 0.0091
47 UPPER AIRWAY OBSTRUCTION 8 0.0090
48 GRIMACING 7 0.0090
49 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 12 0.0089
50 DISTRIBUTIVE SHOCK 20 0.0088
51 PATIENT UNCOOPERATIVE 4 0.0084
52 SUBRETINAL FLUID 9 0.0082
53 BEHAVIOUR DISORDER 44 0.0081
54 NEGATIVISM 6 0.0079
55 EDUCATIONAL PROBLEM 13 0.0078
56 ADHESIVE TAPE USE 3 0.0078
57 POLYCYSTIC OVARIAN SYNDROME 3 0.0078
58 HYPERTENSIVE EMERGENCY 9 0.0076
59 SOCIAL ANXIETY DISORDER 5 0.0076
60 ATTENTION DEFICIT HYPERACTIVITY DISORDER 32 0.0076
61 ANTICHOLINERGIC SYNDROME 12 0.0075
62 ANION GAP ABNORMAL 2 0.0075
63 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 3 0.0071
64 ELECTROCARDIOGRAM T WAVE ABNORMAL 11 0.0070
65 VASOPLEGIA SYNDROME 11 0.0067
66 ALLERGY TO PLANTS 3 0.0066
67 CHANGE IN SEIZURE PRESENTATION 4 0.0062
68 SINUS BRADYCARDIA 58 0.0060
69 POSTURING 3 0.0058
70 PROTRUSION TONGUE 3 0.0051
71 SEDATION COMPLICATION 13 0.0051
72 CARDIAC ANEURYSM 5 0.0050
73 HYPOPROTEINAEMIA 9 0.0047
74 PRESSURE OF SPEECH 3 0.0046
75 AGGRESSION 230 0.0046
76 TRANSCRIPTION MEDICATION ERROR 7 0.0045
77 INHIBITORY DRUG INTERACTION 7 0.0044
78 DRUG EFFECT VARIABLE 5 0.0044
79 PRIAPISM 15 0.0043
80 INSULIN RESISTANCE 9 0.0043
81 PROPOFOL INFUSION SYNDROME 3 0.0043
82 CATATONIA 22 0.0042
83 PSYCHOMOTOR HYPERACTIVITY 69 0.0042
84 SYMPTOM MASKED 3 0.0041
85 CLONIC CONVULSION 3 0.0041
86 EXCESSIVE EYE BLINKING 6 0.0041
87 EOSINOPHIL COUNT ABNORMAL 3 0.0040
88 ENURESIS 16 0.0040
89 DISTURBANCE IN SOCIAL BEHAVIOUR 9 0.0038
90 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 19 0.0037
91 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3 0.0037
92 EOSINOPHILIC OESOPHAGITIS 10 0.0036
93 DRUG TOLERANCE 18 0.0036
94 STRESS CARDIOMYOPATHY 20 0.0034
95 HYPORESPONSIVE TO STIMULI 4 0.0034
96 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 3 0.0034
97 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
98 PHYSICAL ASSAULT 7 0.0033
99 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
100 STARING 8 0.0033
101 STEREOTYPY 3 0.0032
102 IMMUNE THROMBOCYTOPENIC PURPURA 9 0.0032
103 AFFECTIVE DISORDER 25 0.0032
104 PYELOCALIECTASIS 3 0.0031
105 DISINHIBITION 5 0.0031
106 SELF-INJURIOUS IDEATION 13 0.0031
107 SEROTONIN SYNDROME 59 0.0031
108 NEPHROGENIC ANAEMIA 14 0.0030
109 TROPONIN I INCREASED 5 0.0030
110 HYPERAMMONAEMIA 15 0.0030
111 AUTISM 3 0.0030
112 IMPULSE-CONTROL DISORDER 6 0.0029
113 AUTISM SPECTRUM DISORDER 16 0.0029
114 MAST CELL ACTIVATION SYNDROME 4 0.0028
115 INFUSION SITE DISCHARGE 5 0.0028
116 SLEEP DEFICIT 6 0.0028
117 NEUROMYOPATHY 3 0.0028
118 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 19 0.0028
119 HOSTILITY 7 0.0028
120 JUDGEMENT IMPAIRED 4 0.0028
121 PRODUCT NAME CONFUSION 3 0.0027
122 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
123 BRADYCARDIA 145 0.0027
124 DARK CIRCLES UNDER EYES 4 0.0027
125 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9 0.0027
126 BLUNTED AFFECT 2 0.0027
127 INTENTIONAL OVERDOSE 174 0.0027
128 AMINO ACID LEVEL INCREASED 2 0.0027
129 ABNORMAL BEHAVIOUR 106 0.0027
130 SCREAMING 17 0.0027
131 MOANING 3 0.0026
132 INTENTIONAL SELF-INJURY 52 0.0026
133 SEDATION 66 0.0025
134 DYSTONIA 48 0.0025
135 ANGER 82 0.0024
136 ELECTROCARDIOGRAM QT PROLONGED 87 0.0024
137 DRUG LEVEL ABOVE THERAPEUTIC 11 0.0024
138 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
139 OBSESSIVE-COMPULSIVE DISORDER 19 0.0024
140 TORTICOLLIS 5 0.0024
141 SUSPECTED SUICIDE 11 0.0023
142 CEREBRAL DISORDER 17 0.0023
143 BIPOLAR I DISORDER 5 0.0023
144 LOGORRHOEA 8 0.0023
145 HIRSUTISM 3 0.0023
146 FRUSTRATION TOLERANCE DECREASED 18 0.0022
147 HOMICIDAL IDEATION 9 0.0022
148 AGORAPHOBIA 3 0.0022
149 BEZOAR 3 0.0022
150 REACTION TO EXCIPIENT 5 0.0022
151 CATHETER SITE SWELLING 2 0.0021
152 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
153 AGITATION 154 0.0021
154 DYSPHEMIA 9 0.0021
155 DRUG DELIVERY SYSTEM ISSUE 4 0.0020
156 DROOLING 14 0.0020
157 NEUROLEPTIC MALIGNANT SYNDROME 24 0.0020
158 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 11 0.0020
159 TACHYPHRENIA 7 0.0020
160 PITUITARY TUMOUR 3 0.0020
161 CRANIOCEREBRAL INJURY 6 0.0020
162 IRRITABILITY 118 0.0020
163 THERAPY CHANGE 19 0.0019
164 ORTHOSTATIC HYPOTENSION 33 0.0019
165 CARDIAC DYSFUNCTION 7 0.0019
166 RESPIRATORY DEPRESSION 23 0.0019
167 AFFECT LABILITY 18 0.0019
168 PRODUCT SUBSTITUTION ISSUE 107 0.0019
169 MANIA 30 0.0018
170 INTERCEPTED PRODUCT DISPENSING ERROR 3 0.0018
171 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
172 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
173 SLEEP TALKING 3 0.0018
174 HYPERTONIC BLADDER 5 0.0017
175 PRODUCT CONTAINER SEAL ISSUE 3 0.0017
176 OTORRHOEA 3 0.0017
177 DRUG WITHDRAWAL CONVULSIONS 3 0.0017
178 RECALLED PRODUCT ADMINISTERED 16 0.0017
179 PRODUCT PREPARATION ISSUE 11 0.0017
180 MEDICATION RESIDUE PRESENT 8 0.0017
181 INFUSION SITE REACTION 5 0.0017
182 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
183 SLEEP TERROR 7 0.0017
184 WRONG DOSE 4 0.0017
185 REBOUND ACID HYPERSECRETION 5 0.0017
186 CARDIAC FAILURE ACUTE 11 0.0016
187 BLOOD THYROID STIMULATING HORMONE ABNORMAL 3 0.0016
188 HYPERTRICHOSIS 3 0.0016
189 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
190 EMOTIONAL DISORDER 49 0.0016
191 DYSPHORIA 8 0.0016
192 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0016
193 ADJUSTMENT DISORDER 2 0.0015
194 THERAPY PARTIAL RESPONDER 24 0.0015
195 DEVICE MECHANICAL ISSUE 21 0.0015
196 PERSONALITY DISORDER 4 0.0015
197 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
198 INFUSION SITE HAEMORRHAGE 5 0.0015
199 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
200 HYPERPHAGIA 6 0.0015
201 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
202 AREFLEXIA 4 0.0015
203 FOAMING AT MOUTH 3 0.0015
204 MICROCYTIC ANAEMIA 3 0.0014
205 SUICIDAL BEHAVIOUR 6 0.0014
206 PRE-EXISTING CONDITION IMPROVED 9 0.0014
207 DISSOCIATION 11 0.0014
208 DEVICE MATERIAL ISSUE 3 0.0014
209 DRUG TOLERANCE DECREASED 4 0.0014
210 THERAPEUTIC RESPONSE CHANGED 9 0.0014
211 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
212 INFUSION SITE BRUISING 3 0.0014
213 BIPOLAR DISORDER 15 0.0014
214 HYPOMANIA 5 0.0014
215 GROWTH RETARDATION 4 0.0014
216 LETHARGY 78 0.0014
217 TRISMUS 7 0.0014
218 SNORING 5 0.0013
219 HALLUCINATION, AUDITORY 21 0.0013
220 TROPONIN INCREASED 10 0.0013
221 INCREASED APPETITE 25 0.0013
222 BRUXISM 7 0.0013
223 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
224 RHINOVIRUS INFECTION 5 0.0013
225 RESPIRATORY RATE DECREASED 4 0.0013
226 RESPIRATORY ACIDOSIS 5 0.0013
227 INFUSION SITE PRURITUS 4 0.0013
228 URINARY TRACT OBSTRUCTION 3 0.0013
229 SINUS OPERATION 3 0.0013
230 MOOD SWINGS 40 0.0013
231 MIOSIS 10 0.0012
232 TOXICITY TO VARIOUS AGENTS 207 0.0012
233 HAEMATOLOGICAL INFECTION 3 0.0012
234 EXPIRED DEVICE USED 4 0.0012
235 CATHETER SITE HAEMORRHAGE 3 0.0012
236 HYPERPARATHYROIDISM SECONDARY 3 0.0012
237 SINUS TACHYCARDIA 17 0.0012
238 POOR QUALITY DEVICE USED 12 0.0012
239 PRODUCT DISPENSING ERROR 26 0.0012
240 POST-TRAUMATIC STRESS DISORDER 8 0.0012
241 EXPOSURE VIA INGESTION 3 0.0012
242 INFUSION SITE ERYTHEMA 10 0.0012
243 WRONG PRODUCT ADMINISTERED 8 0.0012
244 INITIAL INSOMNIA 12 0.0012
245 ABNORMAL UTERINE BLEEDING 3 0.0012
246 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
247 SUICIDE ATTEMPT 70 0.0012
248 REBOUND EFFECT 13 0.0011
249 SENSITIVITY TO WEATHER CHANGE 6 0.0011
250 SOMNOLENCE 229 0.0011
251 TREATMENT FAILURE 94 0.0011
252 RESTLESSNESS 41 0.0011
253 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0011
254 SALIVARY HYPERSECRETION 11 0.0011
255 DISTURBANCE IN ATTENTION 59 0.0011
256 SUICIDAL IDEATION 100 0.0011
257 MYDRIASIS 14 0.0011
258 MUSCLE RIGIDITY 13 0.0011
259 DRUG SCREEN FALSE POSITIVE 3 0.0011
260 CYSTIC FIBROSIS 6 0.0011
261 ELECTRIC SHOCK SENSATION 3 0.0011
262 PRESYNCOPE 26 0.0011
263 BLADDER SPASM 2 0.0011
264 SOMNAMBULISM 7 0.0011
265 BLOOD PROLACTIN INCREASED 5 0.0011
266 CATHETER SITE INFECTION 4 0.0011
267 OXYGEN SATURATION ABNORMAL 3 0.0011
268 DRUG INTERACTION 166 0.0010
269 IMPAIRED QUALITY OF LIFE 15 0.0010
270 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
271 AKATHISIA 14 0.0010
272 DYSARTHRIA 38 0.0010
273 COMA 48 0.0010
274 INABILITY TO AFFORD MEDICATION 10 0.0010
275 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
276 MYOSITIS 9 0.0010
277 ARTERIOSPASM CORONARY 4 0.0010
278 BLINDNESS UNILATERAL 14 0.0010
279 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
280 SELF INJURIOUS BEHAVIOUR 3 0.0010
281 BREAST DISORDER 2 0.0010
282 PETIT MAL EPILEPSY 5 0.0010
283 DRUG LEVEL INCREASED 16 0.0010
284 SOCIAL PROBLEM 4 0.0010
285 BLOOD CREATININE DECREASED 3 0.0010
286 WITHDRAWAL SYNDROME 40 0.0010
287 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
288 INTENTIONAL DOSE OMISSION 27 0.0009
289 HYPOTENSION 189 0.0009
290 PRODUCT DISPENSING ISSUE 4 0.0009
291 TEARFULNESS 4 0.0009
292 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
293 PRODUCT FORMULATION ISSUE 6 0.0009
294 NEAR DEATH EXPERIENCE 3 0.0009
295 APPETITE DISORDER 6 0.0009
296 DEVICE INFORMATION OUTPUT ISSUE 7 0.0009
297 STREPTOCOCCAL INFECTION 5 0.0009
298 BRAIN FOG 14 0.0009
299 PRODUCT PHYSICAL ISSUE 18 0.0009
300 APATHY 13 0.0009
301 STATUS EPILEPTICUS 10 0.0009
302 BLOOD LOSS ANAEMIA 2 0.0009
303 GRANULOCYTOPENIA 5 0.0009
304 DERMATITIS CONTACT 10 0.0009
305 SEIZURE 101 0.0009
306 GYNAECOMASTIA 27 0.0009
307 BRAIN OEDEMA 11 0.0009
308 PARANOIA 15 0.0009
309 BLOOD URIC ACID INCREASED 5 0.0009
310 FORMICATION 6 0.0009
311 MOOD ALTERED 23 0.0008
312 PRODUCT CONTAMINATION 3 0.0008
313 SKIN WEEPING 3 0.0008
314 PRODUCT SUPPLY ISSUE 6 0.0008
315 PRODUCT AVAILABILITY ISSUE 19 0.0008
316 PHARYNGITIS STREPTOCOCCAL 9 0.0008
317 COMPLETED SUICIDE 69 0.0008
318 MENTAL DISORDER 36 0.0008
319 DIZZINESS POSTURAL 8 0.0008
320 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
321 PARKINSONISM 8 0.0008
322 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
323 RENAL CELL CARCINOMA 4 0.0008
324 PARADOXICAL DRUG REACTION 3 0.0008
325 TACHYCARDIA 72 0.0008
326 SKIN HAEMORRHAGE 12 0.0008
327 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5 0.0008
328 MIDDLE INSOMNIA 15 0.0008
329 AUTOIMMUNE THYROIDITIS 3 0.0008
330 CARDIOTOXICITY 7 0.0008
331 INSURANCE ISSUE 12 0.0008
332 THIRST 14 0.0008
333 DEVICE PHYSICAL PROPERTY ISSUE 6 0.0008
334 EUPHORIC MOOD 8 0.0008
335 ENCEPHALOPATHY 19 0.0008
336 HYPERPROLACTINAEMIA 5 0.0008
337 APNOEA 6 0.0008
338 SKIN FISSURES 15 0.0008
339 HYPERSOMNIA 22 0.0008
340 BLOOD LACTIC ACID INCREASED 4 0.0008
341 POLYDIPSIA 3 0.0008
342 PRODUCT DISTRIBUTION ISSUE 7 0.0008
343 OBESITY 12 0.0008
344 EATING DISORDER 16 0.0008
345 DIABETIC KETOACIDOSIS 18 0.0007
346 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
347 OVERWEIGHT 4 0.0007
348 POOR QUALITY SLEEP 16 0.0007
349 PRODUCT TASTE ABNORMAL 10 0.0007
350 IMPAIRED GASTRIC EMPTYING 10 0.0007
351 ASPIRATION 8 0.0007
352 COGNITIVE DISORDER 34 0.0007
353 HAIR GROWTH ABNORMAL 5 0.0007
354 HEART RATE ABNORMAL 4 0.0007
355 HALLUCINATIONS, MIXED 3 0.0007
356 TONGUE DISCOMFORT 3 0.0007
357 DEPRESSED MOOD 37 0.0007
358 PRODUCT USE COMPLAINT 11 0.0007
359 UNRESPONSIVE TO STIMULI 18 0.0007
360 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
361 CHAPPED LIPS 3 0.0007
362 DYSKINESIA 28 0.0007
363 CRYING 25 0.0007
364 PULMONARY FUNCTION TEST DECREASED 3 0.0007
365 MAJOR DEPRESSION 5 0.0007
366 ACCIDENTAL OVERDOSE 25 0.0007
367 SEXUAL DYSFUNCTION 8 0.0007
368 SLEEP DISORDER 48 0.0007
369 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
370 PHYSICAL DISABILITY 3 0.0007
371 INSOMNIA 180 0.0007
372 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
373 ATAXIA 8 0.0007
374 PRESCRIBED OVERDOSE 13 0.0007
375 PULMONARY OEDEMA 30 0.0007
376 BRAIN HERNIATION 2 0.0007
377 DEVICE BREAKAGE 27 0.0007
378 GASTROENTERITIS VIRAL 12 0.0007
379 DERMATITIS ATOPIC 35 0.0007
380 HALLUCINATION 50 0.0007
381 HALLUCINATION, VISUAL 14 0.0007
382 END STAGE RENAL DISEASE 12 0.0007
383 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
384 ATRIOVENTRICULAR BLOCK 5 0.0006
385 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
386 SCOLIOSIS 4 0.0006
387 THINKING ABNORMAL 12 0.0006
388 EAR INFECTION 17 0.0006
389 BLEPHAROSPASM 4 0.0006
390 PULSE ABSENT 3 0.0006
391 VENTRICULAR FIBRILLATION 7 0.0006
392 ANXIETY 179 0.0006
393 TRANSPLANT REJECTION 5 0.0006
394 INFUSION SITE PAIN 8 0.0006
395 HEPATITIS ACUTE 4 0.0006
396 MENTAL STATUS CHANGES 17 0.0006
397 EXPIRED DRUG ADMINISTERED 3 0.0006
398 DELIRIUM 21 0.0006
399 MENSTRUAL DISORDER 5 0.0006
400 PROTEIN URINE PRESENT 3 0.0006
401 FLUID INTAKE REDUCED 3 0.0006
402 DEVICE LEAKAGE 26 0.0006
403 ANXIETY DISORDER 2 0.0006
404 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
405 WEIGHT INCREASED 133 0.0006
406 HYPOTHERMIA 6 0.0006
407 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
408 SLUGGISHNESS 6 0.0006
409 ABNORMAL LOSS OF WEIGHT 4 0.0006
410 ENDOCARDITIS 3 0.0006
411 TREATMENT NONCOMPLIANCE 32 0.0006
412 PRODUCT QUALITY ISSUE 79 0.0006
413 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
414 DELUSION 9 0.0006
415 THERAPY NON-RESPONDER 26 0.0006
416 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
417 HYSTERECTOMY 5 0.0006
418 MALABSORPTION 3 0.0006
419 APPLICATION SITE ERYTHEMA 15 0.0006
420 URINARY RETENTION 19 0.0006
421 BRONCHIOLITIS 2 0.0006
422 INCONTINENCE 6 0.0006
423 ABNORMAL WEIGHT GAIN 7 0.0006
424 NYSTAGMUS 3 0.0006
425 LEARNING DISABILITY 3 0.0006
426 RETCHING 12 0.0006
427 APPLICATION SITE IRRITATION 7 0.0006
428 DRUG DOSE OMISSION BY DEVICE 44 0.0006
429 SENSORY DISTURBANCE 9 0.0006
430 PRODUCT ADHESION ISSUE 20 0.0006
431 CARDIOGENIC SHOCK 8 0.0006
432 DECREASED ACTIVITY 6 0.0006
433 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
434 NONSPECIFIC REACTION 3 0.0005
435 PRODUCT ADMINISTRATION ERROR 11 0.0005
436 AMYLASE INCREASED 2 0.0005
437 PSYCHIATRIC SYMPTOM 4 0.0005
438 PSYCHOTIC DISORDER 16 0.0005
439 ARTHROPOD BITE 4 0.0005
440 DIPLOPIA 14 0.0005
441 INTRACRANIAL PRESSURE INCREASED 3 0.0005
442 MENTAL IMPAIRMENT 13 0.0005
443 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
444 MOVEMENT DISORDER 17 0.0005
445 BLOOD PRESSURE DECREASED 35 0.0005
446 LACTIC ACIDOSIS 17 0.0005
447 EXERCISE TOLERANCE DECREASED 3 0.0005
448 DRUG PRESCRIBING ERROR 10 0.0005
449 NIGHTMARE 18 0.0005
450 HYPERVENTILATION 3 0.0005
451 CONCUSSION 4 0.0005
452 METABOLIC DISORDER 3 0.0005
453 OVERDOSE 111 0.0005
454 PULMONARY HAEMORRHAGE 4 0.0005
455 ENERGY INCREASED 3 0.0005
456 URINARY INCONTINENCE 15 0.0005
457 DRY MOUTH 41 0.0005
458 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
459 HUNGER 7 0.0005
460 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
461 TYPE 1 DIABETES MELLITUS 3 0.0005
462 LEUKOCYTOSIS 9 0.0005
463 HYPERHIDROSIS 64 0.0005
464 TARDIVE DYSKINESIA 14 0.0005
465 INJECTION SITE VESICLES 3 0.0005
466 DRUG LEVEL DECREASED 5 0.0005
467 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
468 HYPERTENSION 104 0.0005
469 PARALYSIS 7 0.0005
470 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
471 APPLICATION SITE PRURITUS 11 0.0005
472 TEMPERATURE INTOLERANCE 5 0.0005
473 HEART RATE DECREASED 17 0.0005
474 DEPRESSION 110 0.0005
475 POOR VENOUS ACCESS 5 0.0005
476 GASTROINTESTINAL DISORDER 43 0.0005
477 SWELLING OF EYELID 3 0.0005
478 MUSCLE TWITCHING 11 0.0005
479 INFUSION SITE SWELLING 3 0.0005
480 MULTIPLE INJURIES 3 0.0005
481 SCRATCH 5 0.0005
482 AORTIC VALVE INCOMPETENCE 2 0.0005
483 PRODUCT USE ISSUE 88 0.0005
484 CONDITION AGGRAVATED 142 0.0005
485 PRODUCT CONTAINER ISSUE 4 0.0005
486 PRODUCT USE IN UNAPPROVED INDICATION 115 0.0005
487 TENDON DISORDER 3 0.0005
488 OFF LABEL USE 402 0.0005
489 PRODUCT DOSE OMISSION ISSUE 135 0.0005
490 PRODUCT PRESCRIBING ISSUE 10 0.0005
491 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
492 DYSGRAPHIA 3 0.0005
493 PRODUCT COMMUNICATION ISSUE 4 0.0005
494 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
495 DECREASED APPETITE 105 0.0005
496 BLOOD CREATINE INCREASED 2 0.0005
497 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
498 MENINGITIS 3 0.0004
499 THERAPY CESSATION 23 0.0004
500 FEAR 12 0.0004
501 DRUG EFFECT DECREASED 24 0.0004
502 LOSS OF LIBIDO 4 0.0004
503 ANAL INCONTINENCE 4 0.0004
504 EXTRAPYRAMIDAL DISORDER 11 0.0004
505 DISCOMFORT 27 0.0004
506 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
507 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
508 DRUG INEFFECTIVE 579 0.0004
509 BLOOD TESTOSTERONE DECREASED 3 0.0004
510 EYE MOVEMENT DISORDER 3 0.0004
511 NEPHROTIC SYNDROME 3 0.0004
512 APPLICATION SITE RASH 6 0.0004
513 CARDIAC ARREST 36 0.0004
514 HYPOPHAGIA 11 0.0004
515 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
516 POISONING DELIBERATE 4 0.0004
517 FEELING JITTERY 8 0.0004
518 NERVOUS SYSTEM DISORDER 13 0.0004
519 DRUG INTOLERANCE 40 0.0004
520 CHRONIC KIDNEY DISEASE 31 0.0004
521 COELIAC DISEASE 4 0.0004
522 RENAL TUBULAR NECROSIS 4 0.0004
523 SENSITIVE SKIN 3 0.0004
524 PALLOR 11 0.0004
525 FEELING DRUNK 3 0.0004
526 DEVICE USE ERROR 14 0.0004
527 NEUROTOXICITY 7 0.0004
528 BRAIN INJURY 4 0.0004
529 PRODUCT DOSE OMISSION 26 0.0004
530 MIGRAINE 38 0.0004
531 ILLNESS 41 0.0004
532 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
533 HYPERTHERMIA 3 0.0004
534 SHOCK 9 0.0004
535 DEVICE ADHESION ISSUE 6 0.0004
536 VIRAL INFECTION 13 0.0004
537 CONSTIPATION 85 0.0004
538 RIB FRACTURE 8 0.0004
539 FOOD ALLERGY 3 0.0004
540 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
541 INFLUENZA 43 0.0004
542 RESTLESS LEGS SYNDROME 7 0.0004
543 WEIGHT FLUCTUATION 4 0.0004
544 SPEECH DISORDER 20 0.0004
545 MOUTH ULCERATION 8 0.0004
546 DRUG SCREEN POSITIVE 3 0.0004
547 BLOOD ALBUMIN DECREASED 3 0.0004
548 RENAL CYST 3 0.0004
549 LOSS OF CONSCIOUSNESS 48 0.0004
550 HEREDITARY ANGIOEDEMA 4 0.0004
551 HYPOXIA 13 0.0004
552 DECUBITUS ULCER 3 0.0004
553 SKIN LACERATION 4 0.0004
554 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
555 LOWER LIMB FRACTURE 7 0.0004
556 HEART RATE INCREASED 36 0.0004
557 ECZEMA 19 0.0004
558 THERAPEUTIC RESPONSE DECREASED 22 0.0004
559 TREMOR 60 0.0004
560 FOOT DEFORMITY 4 0.0004
561 HYPERTENSIVE CRISIS 4 0.0004
562 COORDINATION ABNORMAL 5 0.0004
563 DEVICE ISSUE 32 0.0004
564 SEASONAL ALLERGY 5 0.0004
565 CIRCULATORY COLLAPSE 6 0.0004
566 VITAMIN D DECREASED 3 0.0004
567 PSEUDOMONAS INFECTION 3 0.0003
568 SYNCOPE 35 0.0003
569 NEPHROLITHIASIS 16 0.0003
570 HEAD INJURY 11 0.0003
571 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
572 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
573 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 16 0.0003
574 ANHEDONIA 9 0.0003
575 NIGHT SWEATS 11 0.0003
576 ABDOMINAL PAIN UPPER 70 0.0003
577 RESPIRATORY RATE INCREASED 3 0.0003
578 RENAL INJURY 10 0.0003
579 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
580 OROPHARYNGEAL DISCOMFORT 3 0.0003
581 PANIC ATTACK 12 0.0003
582 EXOSTOSIS 3 0.0003
583 DISORIENTATION 13 0.0003
584 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6 0.0003
585 DRUG DISPENSING ERROR 5 0.0003
586 PNEUMONIA BACTERIAL 3 0.0003
587 INCREASED TENDENCY TO BRUISE 3 0.0003
588 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
589 CARDIOMEGALY 4 0.0003
590 GRAND MAL CONVULSION 3 0.0003
591 SPINAL OPERATION 4 0.0003
592 FLUSHING 33 0.0003
593 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
594 PERSONALITY CHANGE 3 0.0003
595 ILEUS 4 0.0003
596 FLANK PAIN 3 0.0003
597 POISONING 4 0.0003
598 CYANOSIS 5 0.0003
599 DIZZINESS 158 0.0003
600 PRODUCT PACKAGING ISSUE 3 0.0003
601 NO ADVERSE EVENT 57 0.0003
602 SLEEP APNOEA SYNDROME 6 0.0003
603 HOSPITALISATION 48 0.0003
604 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
605 ADVERSE DRUG REACTION 28 0.0003
606 DRUG RESISTANCE 8 0.0003
607 CARDIAC FLUTTER 2 0.0003
608 EAR PAIN 6 0.0003
609 AMNESIA 20 0.0003
610 NASAL CONGESTION 18 0.0003
611 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
612 VOMITING 143 0.0003
613 LIGAMENT SPRAIN 3 0.0003
614 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
615 VENTRICULAR TACHYCARDIA 5 0.0003
616 BLOOD PRESSURE INCREASED 46 0.0003
617 FUNGAL INFECTION 10 0.0003
618 BLOOD UREA INCREASED 5 0.0003
619 PAIN OF SKIN 8 0.0003
620 EXTRA DOSE ADMINISTERED 12 0.0003
621 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60 0.0003
622 FEEDING DISORDER 6 0.0003
623 EYE SWELLING 11 0.0003
624 ARRHYTHMIA 14 0.0003
625 DRY THROAT 3 0.0003
626 PARAESTHESIA 46 0.0003
627 SCAR 5 0.0003
628 ASTHMA 33 0.0003
629 RESPIRATORY ARREST 8 0.0003
630 DEVICE DEFECTIVE 5 0.0003
631 RHABDOMYOLYSIS 12 0.0003
632 FEELING COLD 8 0.0003
633 WEIGHT DECREASED 80 0.0003
634 CARPAL TUNNEL SYNDROME 4 0.0003
635 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
636 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
637 JOINT DISLOCATION 3 0.0003
638 COLD SWEAT 5 0.0003
639 FATIGUE 220 0.0003
640 PALPITATIONS 33 0.0003
641 EMOTIONAL DISTRESS 34 0.0003
642 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
643 PARAESTHESIA ORAL 4 0.0003
644 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
645 FLUID RETENTION 14 0.0003
646 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
647 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
648 SINUSITIS 28 0.0003
649 GASTROINTESTINAL PAIN 3 0.0003
650 APPLICATION SITE PAIN 6 0.0003
651 TOOTH FRACTURE 3 0.0003
652 ANAPHYLACTIC SHOCK 7 0.0003
653 DRUG WITHDRAWAL SYNDROME NEONATAL 4 0.0003
654 GAIT INABILITY 9 0.0003
655 MALNUTRITION 3 0.0003
656 OCULAR DISCOMFORT 3 0.0003
657 HEADACHE 167 0.0003
658 THERAPY INTERRUPTED 19 0.0003
659 PHOTOPHOBIA 5 0.0003
660 BLOOD SODIUM DECREASED 5 0.0003
661 ECONOMIC PROBLEM 4 0.0003
662 SCAB 3 0.0003
663 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
664 DEHYDRATION 35 0.0003
665 ACIDOSIS 2 0.0003
666 SWELLING FACE 17 0.0003
667 HYPERSENSITIVITY 48 0.0003
668 ELECTROLYTE IMBALANCE 3 0.0003
669 RASH MACULAR 9 0.0003
670 COVID-19 45 0.0003
671 ABDOMINAL DISCOMFORT 43 0.0003
672 CHOKING 5 0.0003
673 SURGERY 15 0.0003
674 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
675 SICKLE CELL ANAEMIA WITH CRISIS 4 0.0003
676 DISABILITY 5 0.0003
677 PNEUMOTHORAX 4 0.0003
678 MYOCLONUS 3 0.0003
679 HYPERLIPIDAEMIA 3 0.0003
680 RASH ERYTHEMATOUS 12 0.0003
681 UPPER LIMB FRACTURE 5 0.0003
682 PRESCRIBED UNDERDOSE 5 0.0003
683 FEELING ABNORMAL 60 0.0003
684 BLOOD DISORDER 2 0.0002
685 RENAL FAILURE 33 0.0002
686 EYE PAIN 14 0.0002
687 RHINORRHOEA 16 0.0002
688 HYPERGLYCAEMIA 9 0.0002
689 MUSCLE TIGHTNESS 4 0.0002
690 NEURALGIA 6 0.0002
691 BLOOD POTASSIUM INCREASED 4 0.0002
692 BACK DISORDER 4 0.0002
693 INJECTION SITE URTICARIA 6 0.0002
694 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
695 BRONCHITIS 18 0.0002
696 TENDON RUPTURE 3 0.0002
697 STAPHYLOCOCCAL INFECTION 8 0.0002
698 PHOTOSENSITIVITY REACTION 4 0.0002
699 LIP SWELLING 8 0.0002
700 INTENTIONAL PRODUCT MISUSE 21 0.0002
701 RASH PRURITIC 13 0.0002
702 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
703 ADVERSE EVENT 22 0.0002
704 NASOPHARYNGITIS 44 0.0002
705 PRODUCT COMPLAINT 6 0.0002
706 RENAL DISORDER 11 0.0002
707 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
708 CATARACT 14 0.0002
709 NAUSEA 186 0.0002
710 JOINT INJURY 5 0.0002
711 IMPAIRED WORK ABILITY 5 0.0002
712 RESPIRATORY FAILURE 17 0.0002
713 UNDERDOSE 17 0.0002
714 INFLAMMATION 12 0.0002
715 MUSCULOSKELETAL DISCOMFORT 4 0.0002
716 DRY SKIN 31 0.0002
717 APHASIA 7 0.0002
718 OCULAR HYPERAEMIA 11 0.0002
719 INJECTION SITE INDURATION 3 0.0002
720 FALL 76 0.0002
721 AMENORRHOEA 4 0.0002
722 INCORRECT DOSE ADMINISTERED 52 0.0002
723 PULMONARY CONGESTION 3 0.0002
724 PERIPHERAL SWELLING 35 0.0002
725 LIMB DISCOMFORT 7 0.0002
726 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
727 EYE IRRITATION 13 0.0002
728 TRANSAMINASES INCREASED 5 0.0002
729 UNEVALUABLE EVENT 17 0.0002
730 ORAL PAIN 5 0.0002
731 GOUT 4 0.0002
732 RASH 97 0.0002
733 SINUS CONGESTION 3 0.0002
734 OEDEMA 12 0.0002
735 LIMB INJURY 6 0.0002
736 DRY EYE 11 0.0002
737 DRUG EFFECT INCOMPLETE 8 0.0002
738 CYSTITIS 7 0.0002
739 PERIPHERAL COLDNESS 3 0.0002
740 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
741 INJECTION SITE MASS 8 0.0002
742 EPISTAXIS 16 0.0002
743 CHOLELITHIASIS 7 0.0002
744 VERTIGO 13 0.0002
745 DEVICE OCCLUSION 3 0.0002
746 EYE DISORDER 7 0.0002
747 FEELING HOT 13 0.0002
748 FLATULENCE 12 0.0002
749 ABDOMINAL DISTENSION 22 0.0002
750 PRODUCT PRESCRIBING ERROR 5 0.0002
751 CONVULSION 12 0.0002
752 INJECTION SITE SWELLING 16 0.0002
753 EYE PRURITUS 7 0.0002
754 ACUTE RESPIRATORY FAILURE 4 0.0002
755 ATELECTASIS 2 0.0002
756 COUGH 58 0.0002
757 LOCALISED INFECTION 5 0.0002
758 ABDOMINAL PAIN 48 0.0002
759 LIVER FUNCTION TEST ABNORMAL 6 0.0002
760 PRURITUS 79 0.0002
761 DYSPHONIA 12 0.0002
762 CHEST PAIN 38 0.0002
763 OEDEMA PERIPHERAL 25 0.0002
764 CONFUSIONAL STATE 33 0.0002
765 VISION BLURRED 28 0.0002
766 KIDNEY INFECTION 4 0.0002
767 SINUS DISORDER 4 0.0002
768 DYSPHAGIA 19 0.0002
769 BLOOD POTASSIUM DECREASED 6 0.0002
770 CARDIAC FAILURE 16 0.0002
771 OSTEOPENIA 3 0.0002
772 CONTUSION 19 0.0002
773 URTICARIA 33 0.0002
774 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
775 EPILEPSY 6 0.0002
776 OXYGEN SATURATION DECREASED 11 0.0002
777 INJECTION SITE PAIN 60 0.0002
778 DRUG ADMINISTRATION ERROR 6 0.0002
779 PRODUCT PREPARATION ERROR 4 0.0002
780 OROPHARYNGEAL PAIN 18 0.0002
781 ANKLE FRACTURE 3 0.0002
782 SWELLING 18 0.0002
783 POLLAKIURIA 8 0.0002
784 NERVOUSNESS 10 0.0002
785 DEAFNESS 5 0.0002
786 SKIN EXFOLIATION 16 0.0002
787 ACUTE KIDNEY INJURY 29 0.0002
788 INJECTION SITE REACTION 13 0.0002
789 BODY HEIGHT DECREASED 2 0.0002
790 IRRITABLE BOWEL SYNDROME 4 0.0002
791 IMPAIRED HEALING 6 0.0002
792 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
793 DRUG WITHDRAWAL SYNDROME 16 0.0002
794 URINARY TRACT INFECTION 31 0.0002
795 DEVICE DIFFICULT TO USE 12 0.0002
796 PROCEDURAL PAIN 5 0.0002
797 MEDICATION ERROR 10 0.0002
798 MUSCLE SPASMS 33 0.0002
799 RASH PAPULAR 4 0.0002
800 SNEEZING 4 0.0002
801 TYPE 2 DIABETES MELLITUS 6 0.0002
802 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
803 PAIN IN JAW 5 0.0002
804 TINNITUS 8 0.0002
805 SKIN DISCOLOURATION 8 0.0002
806 HERPES ZOSTER 10 0.0002
807 DIARRHOEA 112 0.0002
808 GAIT DISTURBANCE 33 0.0002
809 NEEDLE ISSUE 5 0.0002
810 BLOOD CHOLESTEROL INCREASED 8 0.0002
811 ACNE 13 0.0002
812 PNEUMONIA 55 0.0002
813 HEAD DISCOMFORT 3 0.0002
814 BLOOD IRON DECREASED 2 0.0002
815 CARDIO-RESPIRATORY ARREST 7 0.0002
816 BLOOD PRESSURE FLUCTUATION 4 0.0002
817 BLOOD GLUCOSE DECREASED 8 0.0002
818 COMPLICATION OF DEVICE REMOVAL 3 0.0002
819 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
820 ASTHENIA 62 0.0002
821 ADRENAL INSUFFICIENCY 2 0.0002
822 BONE DISORDER 3 0.0002
823 FIBROMYALGIA 4 0.0002
824 CHILLS 19 0.0002
825 ABASIA 4 0.0002
826 CONJUNCTIVITIS 3 0.0002
827 AGEUSIA 4 0.0002
828 PNEUMONIA ASPIRATION 4 0.0002
829 SWOLLEN TONGUE 5 0.0002
830 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
831 BLOOD GLUCOSE INCREASED 30 0.0002
832 INFECTION 23 0.0002
833 FOOT FRACTURE 3 0.0002
834 GASTRIC ULCER 3 0.0002
835 PROTEINURIA 3 0.0002
836 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
837 METABOLIC ACIDOSIS 5 0.0002
838 CHEST DISCOMFORT 16 0.0002
839 POST PROCEDURAL COMPLICATION 3 0.0002
840 SKIN ULCER 4 0.0002
841 EXPOSURE VIA SKIN CONTACT 4 0.0002
842 ORAL HERPES 3 0.0002
843 RESPIRATORY TRACT INFECTION 4 0.0002
844 ARTHRITIS 12 0.0002
845 DYSPEPSIA 15 0.0002
846 GASTRITIS 4 0.0002
847 ANKYLOSING SPONDYLITIS 2 0.0002
848 HAEMATOCRIT DECREASED 3 0.0002
849 DRUG DOSE OMISSION 25 0.0002
850 BLOOD PRESSURE ABNORMAL 3 0.0002
851 COMPLICATION OF DEVICE INSERTION 3 0.0002
852 BALANCE DISORDER 13 0.0002
853 MENSTRUATION IRREGULAR 4 0.0001
854 PAIN IN EXTREMITY 44 0.0001
855 FULL BLOOD COUNT DECREASED 3 0.0001
856 MALAISE 65 0.0001
857 ILL-DEFINED DISORDER 9 0.0001
858 PLEURAL EFFUSION 9 0.0001
859 PYREXIA 51 0.0001
860 DISEASE RECURRENCE 7 0.0001
861 HEPATIC ENZYME INCREASED 10 0.0001
862 MEMORY IMPAIRMENT 20 0.0001
863 RESPIRATORY DISTRESS 4 0.0001
864 ABNORMAL DREAMS 4 0.0001
865 HAEMOPTYSIS 4 0.0001
866 NECK PAIN 8 0.0001
867 BLISTER 8 0.0001
868 DEVICE MALFUNCTION 10 0.0001
869 RENAL FAILURE ACUTE 6 0.0001
870 MUSCULAR WEAKNESS 16 0.0001
871 BRONCHOSPASM 2 0.0001
872 MOBILITY DECREASED 10 0.0001
873 PRURITUS GENERALISED 3 0.0001
874 DEVICE DISLOCATION 6 0.0001
875 SEPTIC SHOCK 6 0.0001
876 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
877 DYSSTASIA 4 0.0001
878 DYSURIA 5 0.0001
879 GLOSSODYNIA 3 0.0001
880 RESPIRATORY DISORDER 4 0.0001
881 INFLUENZA LIKE ILLNESS 11 0.0001
882 PANCREATITIS ACUTE 3 0.0001
883 CHROMATURIA 3 0.0001
884 DYSPNOEA EXERTIONAL 5 0.0001
885 HEPATIC FAILURE 4 0.0001
886 INTESTINAL OBSTRUCTION 5 0.0001
887 DIABETES MELLITUS 10 0.0001
888 INJECTION SITE RASH 4 0.0001
889 ACUTE MYELOID LEUKAEMIA 2 0.0001
890 ANAPHYLACTIC REACTION 7 0.0001
891 ERYTHEMA 26 0.0001
892 NEUROPATHY PERIPHERAL 12 0.0001
893 ARTHROPATHY 7 0.0001
894 BACK PAIN 29 0.0001
895 PAIN 76 0.0001
896 HYPOGLYCAEMIA 6 0.0001
897 CEREBRAL INFARCTION 3 0.0001
898 BLINDNESS 5 0.0001
899 LUNG DISORDER 6 0.0001
900 INJECTION SITE ERYTHEMA 15 0.0001
901 EXPIRED PRODUCT ADMINISTERED 4 0.0001
902 DYSPNOEA 68 0.0001
903 ROAD TRAFFIC ACCIDENT 5 0.0001
904 RENAL IMPAIRMENT 10 0.0001
905 CANDIDA INFECTION 2 0.0001
906 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
907 HAEMATEMESIS 3 0.0001
908 OSTEOARTHRITIS 5 0.0001
909 CARDIAC DISORDER 11 0.0001
910 ERECTILE DYSFUNCTION 3 0.0001
911 GASTRIC DISORDER 4 0.0001
912 RECTAL HAEMORRHAGE 5 0.0001
913 STOMATITIS 7 0.0001
914 PSORIASIS 15 0.0001
915 JOINT STIFFNESS 3 0.0001
916 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
917 INJURY 8 0.0001
918 ARTHRALGIA 47 0.0001
919 ANGIOEDEMA 5 0.0001
920 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
921 HAEMATOCHEZIA 6 0.0001
922 DYSGEUSIA 8 0.0001
923 SEPSIS 12 0.0001
924 DEMENTIA 3 0.0001
925 BACTERIAL INFECTION 2 0.0001
926 VISUAL IMPAIRMENT 13 0.0001
927 PRODUCTIVE COUGH 5 0.0001
928 INJECTION SITE PRURITUS 7 0.0001
929 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
930 NEUTROPENIA 14 0.0001
931 PRODUCT STORAGE ERROR 9 0.0001
932 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
933 BURNING SENSATION 7 0.0001
934 CELLULITIS 5 0.0001
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
936 HYPOTHYROIDISM 3 0.0001
937 SKIN DISORDER 3 0.0001
938 HYPONATRAEMIA 5 0.0001
939 SKIN IRRITATION 4 0.0001
940 CARDIAC FAILURE CONGESTIVE 7 0.0001
941 HYPOAESTHESIA 13 0.0001
942 LYMPHADENOPATHY 3 0.0001
943 WHEEZING 5 0.0001
944 PULMONARY EMBOLISM 8 0.0001
945 CEREBRAL HAEMORRHAGE 3 0.0001
946 SKIN BURNING SENSATION 6 0.0001
947 MYALGIA 14 0.0001
948 ALOPECIA 16 0.0001
949 MUSCULOSKELETAL STIFFNESS 7 0.0001
950 ABDOMINAL PAIN LOWER 2 0.0001
951 CARDIOVASCULAR DISORDER 2 0.0001
952 ANAEMIA 15 0.0001
953 DEEP VEIN THROMBOSIS 5 0.0001
954 CEREBROVASCULAR ACCIDENT 13 0.0001
955 DISEASE PROGRESSION 9 0.0001
956 INJECTION SITE BRUISING 6 0.0001
957 INJECTION SITE HAEMORRHAGE 6 0.0001
958 PSORIATIC ARTHROPATHY 3 0.0001
959 OSTEOPOROSIS 3 0.0001
960 DRUG ABUSE 6 0.0001
961 HYPOACUSIS 3 0.0001
962 VAGINAL HAEMORRHAGE 3 0.0001
963 MYOCARDIAL INFARCTION 12 0.0001
964 DRUG DEPENDENCE 11 0.0001
965 ASCITES 2 0.0001
966 LIVER DISORDER 3 0.0001
967 COLITIS ULCERATIVE 3 0.0001
968 HAEMORRHAGE 7 0.0001
969 HOT FLUSH 5 0.0001
970 HYPOKALAEMIA 3 0.0001
971 EXPOSURE DURING PREGNANCY 4 0.0001
972 HAEMOGLOBIN DECREASED 6 0.0001
973 MUSCULOSKELETAL PAIN 3 0.0001
974 PANCREATITIS 3 0.0001
975 PLATELET COUNT DECREASED 6 0.0001
976 ATRIAL FIBRILLATION 5 0.0001
977 THROMBOSIS 4 0.0000
978 JOINT SWELLING 6 0.0000
979 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
980 DEATH 42 0.0000
981 DEVICE EXPULSION 3 0.0000
982 FEBRILE NEUTROPENIA 3 0.0000
983 NEOPLASM MALIGNANT 3 0.0000
984 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
985 THROMBOCYTOPENIA 5 0.0000
986 RHEUMATOID ARTHRITIS 3 0.0000
987 BREAST CANCER 2 0.0000